Pfizer Inc. news

   Watch this stock
Showing stories 11 - 20 of about 201   

Articles published

PFE 30.25 +0.16 (0.53%)
price chart
Healthcare Active Runners: Pfizer Inc. (NYSE:PFE), Abbott Laboratories
Pfizer Inc. (NYSE:PFE) sales still tumbling from the loss of patent protection on its blockbuster cholesterol-lowering drug Lipitor, saw its sales decline to $51.6 billion last year.
Related articles »  
Dow Today: Pfizer (PFE) Lower
Pfizer has a market cap of $195.71 billion and is part of the health care sector and drugs industry. Shares are down 2.5% year-to-date as of Friday's close.
Related articles »  
Vigo County Parks aquire 824 acres from Pfizer Inc.
The Board closed on 824 acres formerly owned by Pfizer Inc on Tuesday. The land is in southern Vigo County, mostly north of Dallas Road.
Pfizer, Lilly Breast Cancer Drugs Slow Tumors in Studies
Experimental breast cancer drugs from Pfizer Inc. (PFE) and Eli Lilly & Co. (LLY) slowed or halted growth of advanced tumors in studies, potentially adding a new treatment option for patients and top-selling therapies for the companies.
Pfizer drug doubles time to breast cancer tumor growth in trial  Chicago Tribune (blog)
Related articles »  
Pfizer: It Never Rains, It Pours
Pfizer has been beaten up these past two days. It was cheap before, now it is cheaper. The stock may be of interest to value investors.
Related articles »  
DRug Active runners: Pfizer Inc. (NYSE:PFE), Sanofi SA (ADR) (NYSE:SNY ...
Three years after Pfizer Inc. (NYSE:PFE) dropped a bombshell on its plans to lay off more than 1000 workers. The biopharmaceutical company has come back with some of the best news, on how it plans to use the vacated Groton site.
Mega Cap Active Stocks: Apple Inc. (NASDAQ:AAPL), Johnson & Johnson ...  Gaining Green
Related articles »  
Pfizer, AstraZeneca, and Novartis Reveal New Business Developments
With small cap biotech companies flooding the news, Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN), and Novartis AG (ADR) (NVS) revealed developments in their businesses.
Related articles »  
Sign in or Register
Healthcare giant, Pfizer Inc. (NYSE:PFE) reported that its experimental anti-cholesterol cure considerably lowered LDL-C cholesterol thought many dosing levels in a Phase 2b study of patients at high risk for cardiovascular events.
Related articles »  
Pfizer Inc. (NYSE:PFE) On The Verge Of Providing Relief To Psoriasis
Tomahawk, WI 03/25/2014 (Basicsmedia) - Pfizer Inc. (NYSE:PFE) today made public the results of oral treatment Psoriasis Trial (OPT) compare (A3921080), a Phase 3 study of Xeljanz (tofacitinib).
Related articles »  
Novartis overtakes Pfizer as top drug company
A robust sales year for three of Novartis Corp.'s medications allowed the firm to pass reeling Pfizer Inc. for the top spot on Modern Healthcare's annual list of largest publicly traded pharmaceutical companies.